Tel Aviv and Harvard University researchers developed mini-human organs-on-a-chip in pursuit of drug development acceleration. Sounding like some sort of science fiction-based activity, the researchers were able to connect nine organs via these mini chips including a...
The Food and Drug Administration’s (FDA) attempts at expediting and streamlining the approval of advanced new medicines is surely appreciated by those in the public that understand the importance of access to such therapies to address serious disease. And in fact,...
William G. Kaelin, Jr. MD won the 2019 Nobel Prize in medicine. His research findings at Dana-Farber are game-changing: a rare disorder called von Hippel Lindau syndrome, triggered when one tumor-suppressor gene called VHL mutates, makes patients more likely to...
A new consortium, based at the Laboratory of Systems Pharmacology (LSP) at Harvard Medical School, has launched an ambitious project titled STOP PAIN (Safe Therapeutic Options for Pain and Inflammation). By combining a wide range of experimental and artificial...
Harvard Medical School researcher Peter Kharchenko and three collaborators have won a six-year multimillion-dollar grant from the European Research Council for their work toward mapping out cellular decision-making during early development in an effort to illuminate...
Moderna Inc. is a clinical-stage biotech venture pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines announced a multi-year research collaboration and associated investment with Harvard University with the...
